Lenz TherapeuticsLENZ
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 78 institutions reported holding Lenz Therapeutics Inc. (LENZ) in their 13F filings, up 13 from Q2 2024. 21 opened new positions and 9 sold out. The largest holders were Ra Capital Management, L.P. ($99.2M), Alpha Wave Global, LP ($85.8M) and Samsara Biocapital, LLC ($28.7M). 2 famous investors held it, including Steve Cohen (0.1% of Point72 Asset Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lenz Therapeutics Inc.
- CUSIP
- 52635N103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 21 | $23.2M |
| Exits | 9 | $4.7M |
All 13F filers, Q2 2024 → Q3 2024: 1,401,230 shares bought and 1,549,164 shares sold, net −147,934 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 78 holders
| Ra Capital Management, L.P. | 1.14% | No change | 4,178,823 | $99.2M |
| Alpha Wave Global, LP | 26.65% | No change | 3,612,211 | $85.8M |
| Samsara Biocapital, LLC | 5.51% | No change | 1,208,473 | $28.7M |
| Vanguard Group Inc. | 0.00% | Add +17.0% | 1,118,817 | $26.6M |
| 72 Investment Holdings, LLC | 51.95% | No change | 1,017,751 | $24.2M |
| Sectoral Asset Management Inc. | 13.70% | Reduce -9.9% | 977,245 | $23.2M |
| BlackRock, Inc. | 0.00% | — | 930,021 | $22.1M |
| Point72 Asset Management | 0.07% | No change | 864,942 | $20.5M |
| RTW Investments, LP | 0.30% | No change | 863,389 | $20.5M |
| Tang Capital Management LLC | 1.30% | Add +2.6% | 766,940 | $18.2M |
| T. Rowe Price Associates Inc. | 0.00% | New | 448,631 | $10.7M |
| EcoR1 Capital, LLC | 0.28% | Reduce -71.6% | 346,772 | $8.2M |
| Geode Capital Management, LLC | 0.00% | Reduce -6.1% | 338,024 | $8.0M |
| State Street Corp. | 0.00% | Add +18.7% | 289,154 | $6.9M |
| Ikarian Capital, LLC | 1.51% | No change | 204,513 | $4.9M |
| Parkman Healthcare Partners LLC | 0.42% | New | 139,357 | $3.3M |
| Northern Trust Corp. | 0.00% | Add +59.1% | 129,639 | $3.1M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +197.5% | 123,371 | $2.9M |
| Alyeska Investment Group, L.P. | 0.01% | Reduce -62.0% | 122,113 | $2.9M |
| Schonfeld Strategic Advisors LLC | 0.02% | New | 107,300 | $2.5M |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Add +0.0% | 83,104 | $2.0M |
| Ameriprise Financial Inc. | 0.00% | New | 64,941 | $1.5M |
| BML Capital Management, LLC | 0.84% | Reduce -6.1% | 60,000 | $1.4M |
| Debussy Capital Management LP | 0.41% | No change | 58,752 | $1.4M |
| Boothbay Fund Management, LLC | 0.04% | No change | 54,379 | $1.3M |
| Morgan Stanley | 0.00% | Reduce -23.7% | 50,478 | $1.2M |
| Renaissance Technologies | 0.00% | Reduce -18.1% | 49,266 | $1.2M |
| BBR Partners, LLC | 0.07% | Add +100.0% | 40,000 | $950K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -8.1% | 34,173 | $812K |
| Goldman Sachs Group Inc. | 0.00% | Add +150.0% | 33,054 | $785K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 31,309 | $743K |
| Bank of New York Mellon Corp | 0.00% | Reduce -25.4% | 29,642 | $704K |
| TD Asset Management Inc | 0.00% | New | 28,310 | $681K |
| Kestra Private Wealth Services, LLC | 0.01% | New | 27,504 | $653K |
| Two Sigma Investments, LP | 0.00% | Reduce -25.6% | 25,507 | $606K |
| Wellington Management Group LLP | 0.00% | New | 24,621 | $585K |
| American Century Companies Inc. | 0.00% | New | 23,875 | $567K |
| Nuveen Asset Management, LLC | 0.00% | No change | 23,130 | $549K |
| Kelleher Financial Advisors | 0.19% | New | 20,773 | $493K |
| Bank of America Corp. | 0.00% | Add +18.8% | 19,851 | $471K |
| Rhumbline Advisers | 0.00% | Add +5.0% | 17,654 | $419K |
| Barclays PLC | 0.00% | Add +273.1% | 16,463 | $391K |
| Rinkey Investments | 0.12% | New | 15,186 | $361K |
| Squarepoint Ops LLC | 0.00% | Add +20.8% | 12,654 | $300K |
| Jane Street Group, LLC | 0.00% | New | 12,027 | $286K |
| Gsa Capital Partners LLP | 0.02% | New | 10,357 | $246K |
| Alliancebernstein L.P. | 0.00% | New | 9,346 | $222K |
| Citigroup Inc. | 0.00% | Reduce -50.5% | 9,147 | $217K |
| MetLife Investment Management, LLC | 0.00% | New | 7,672 | $182K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +324.6% | 6,909 | $164K |
| Corebridge Financial, Inc. | 0.00% | Reduce -0.6% | 6,716 | $159K |
| UBS Group AG | 0.00% | Add +51.3% | 6,145 | $146K |
| Wells Fargo & Company | 0.00% | Add +4.4% | 5,896 | $140K |
| JPMorgan Chase & Co. | 0.00% | Add +5.2% | 5,699 | $135K |
| Deutsche Bank AG | 0.00% | Add +1.1% | 5,353 | $127K |
| SG Americas Securities, LLC | 0.00% | New | 4,523 | $107K |
| New York State Common Retirement Fund | 0.00% | Reduce -0.0% | 3,493 | $83K |
| BNP Paribas Financial Markets | 0.00% | Reduce -83.9% | 2,648 | $63K |
| Royal Bank of Canada | 0.00% | Reduce -3.9% | 1,290 | $30K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 1,231 | $29K |
| CIBC Private Wealth Group LLC | 0.00% | New | 1,146 | $27K |
| Legal & General Group Plc | 0.00% | No change | 1,088 | $26K |
| California State Teachers Retirement System | 0.00% | No change | 910 | $22K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -18.1% | 709 | $17K |
| Raleigh Capital Management Inc. | 0.00% | New | 500 | $12K |
| Planned Solutions, Inc. | 0.00% | New | 217 | $5K |
| FMR LLC | 0.00% | Add +38.1% | 134 | $3K |
| Amalgamated Bank | 0.00% | No change | 135 | $3K |
| GAMMA Investing LLC | 0.00% | Add +164.5% | 82 | $2K |
| Cwm, LLC | 0.00% | Add +225.0% | 26 | $1K |
| Sterling Capital Management LLC | 0.00% | — | 40 | $950 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 28 | $665 |
| Nisa Investment Advisors, LLC | 0.00% | New | 22 | $522 |
| Russell Investments Group, Ltd. | 0.00% | No change | 13 | $309 |
| Arax Advisory Partners | 0.00% | No change | 12 | $285 |
| Smartleaf Asset Management LLC | 0.00% | No change | 11 | $264 |
| Earned Wealth Advisors, LLC | 0.00% | New | 6 | $142 |
| Osaic Holdings, Inc. | 0.00% | No change | 2 | $47 |
"% of holder's portfolio" is LENZ's weight in each manager's 13F, not the share of Lenz Therapeutics Inc. the manager owns.